Search results for "Cardiovascular events"


 
Results 11 - 20 of about 200 for "Cardiovascular events".
Sort by: Relevance | Newest | Oldest

Getting to know GLP-1 receptor agonists

Choosing among glucagon-like peptide-1 (GLP-1) receptor agonists depends on many factors, such as the desired outcome and individual risks among patients.
https://immattersacp.org/archives/2023/03/getting-to-know-glp-1-receptor-agonists.htm
1 Mar 2023

Combined use of ED drugs, nitrates linked with worse outcomes in patients with CAD

Risks of myocardial infarction, heart failure, and mortality were significantly higher in coronary artery disease (CAD) patients taking nitrates and phosphodiesterase-5 inhibitors for erectile dysfunction (ED) than in patients taking nitrates alone.
https://immattersacp.org/weekly/archives/2024/01/16/2.htm
16 Jan 2024

PDE5 inhibitors didn't increase cardiovascular events in men on nitrates for heart disease

A Danish study also found that more men with ischemic heart disease are taking both nitrates and a phosphodiesterase type 5 (PDE5) inhibitor, with the prescription rate increasing 20-fold from 2000 to 2018.
https://immattersacp.org/weekly/archives/2022/04/19/1.htm
19 Apr 2022

MKSAP Quiz: Evaluation for increasingly frequent angina

A 68-year-old man is evaluated for increasingly frequent angina. One month ago, coronary angiography was performed because of the occurrence of angina at lower levels of exertion. Following coronary angiography, the patient increased his dosage of isosorbide mononitrate; however, his exertional chest discomfort worsened. Following a physical exam and electrocardiogram, what is the most appropriate management?
https://immattersacp.org/weekly/archives/2024/01/16/3.htm
16 Jan 2024

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2022/06/latest-updates-on-acps-priorities-initiatives.htm
1 Jun 2022

Cardiovascular events similar, adverse effects worse with chlorthalidone compared to hydrochlorothiazide

Chlorthalidone was associated with a significantly higher risk of hypokalemia, hyponatremia, acute renal failure, chronic kidney disease, type 2 diabetes, and abnormal weight gain.
https://immattersacp.org/weekly/archives/2020/02/25/2.htm
25 Feb 2020

RSV vaccine approved; several actions on opioids

This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2023/06/rsv-vaccine-approved-several-actions-on-opioids.htm
1 Jun 2023

Lack of access to PCSK9 inhibitors associated with cardiovascular events

Risk for myocardial infarction, unstable angina, acute ischemic heart disease, ischemic stroke, percutaneous coronary intervention, coronary artery bypass graft, and cardiac arrest was higher in patients whose prescription for a PCSK9 inhibitor was denied or abandoned.
https://immattersacp.org/weekly/archives/2019/07/30/2.htm
30 Jul 2019

Preprocedural statins reduce risk of postprocedure cardiovascular events

Tiotropium improves asthma symptoms as well as salmeterol
https://immattersacp.org/weekly/archives/2010/09/28/5.htm
28 Sep 2010

Details on recently authorized COVID-19 vaccine

This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2022/09/details-on-recently-authorized-covid-19-vaccine.htm
1 Sep 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next